Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income (loss)	$ (190,945)	$ 802,508	$ 326,328
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	363,027	346,151	363,381
Goodwill and asset impairment	654,084	0	0
Lower of cost or market inventory valuation adjustment	(291,938)	226,979	397,478
Net loss of equity method investments, inclusive of distributions	961	8,613	5,257
(Gain) loss on early extinguishment of debt	8,718	(3,788)	1,489
Gain on sale of assets	(72)	(8,677)	866
Deferred income taxes	98,592	(146,136)	(193,662)
Equity-based compensation expense	25,561	30,367	29,598
Change in fair value – derivative instruments	(12,155)	38,525	(22,668)
(Increase) decrease in current assets:
Accounts receivable	(127,221)	238,392	108,876
Inventories	(1,869)	(33,717)	(78,842)
Income taxes receivable	(68,371)	11,719	94,237
Prepayments and other	16,555	13,291	1,486
Increase (decrease) in current liabilities:
Accounts payable	247,603	(406,339)	(217,541)
Income taxes payable	(8,142)	(11,500)	19,642
Accrued liabilities	16,142	(6,924)	8,047
Turnaround expenditures	(125,254)	(89,365)	(96,803)
Other, net	(3,005)	(30,473)	13,159
Net cash provided by operating activities	602,271	979,626	758,596
Cash flows from investing activities:
Additions to properties, plants and equipment	(372,195)	(483,034)	(366,135)
Purchase of equity method investment - HEP	(42,627)	(55,032)
Proceeds from sale of assets	849	19,264	16,633
Purchases of marketable securities	(546,632)	(509,338)	(1,025,602)
Sales and maturities of marketable securities	266,603	839,513	1,276,447
Other, net	0	0	5,021
Net cash used for investing activities	(801,597)	(381,748)	(292,322)
Cash flows from financing activities:
Proceeds from issuance of senior notes - HFC	992,550	0	0
Net proceeds from issuance of term loan	350,000	0	0
Redemption of senior notes	0	(155,156)	0
Redemption of senior notes - HEP		(155,156)	(156,188)
Repayment of financing obligation	(39,500)	0	0
Net proceeds from common unit offerings - HEP	125,870	0	0
Repayment of term loan	(350,000)	0	0
Purchase of treasury stock	(133,430)	(742,823)	(158,847)
Dividends	(234,004)	(246,908)	(647,197)
Distributions to noncontrolling interest	(92,607)	(83,268)	(78,202)
Excess tax benefit from equity-based compensation	0	0	2,040
Other, net	(10,507)	(12,175)	(7,998)
Net cash used for financing activities	843,372	(1,099,330)	(838,392)
Cash and cash equivalents:
Increase (decrease) for the period	644,046	(501,452)	(372,118)
Beginning of period	66,533	567,985	940,103
End of period	710,579	66,533	567,985
Cash paid during the period for:
Interest	54,074	46,442	55,716
Income taxes	40,236	586,447	237,907
HEP
Cash flows from investing activities:
Additions to properties, plants and equipment	(107,595)	(193,121)	(198,686)
Purchase of equity method investment - HEP	(42,627)	(55,032)	0
Cash flows from financing activities:
Borrowings under credit agreement – HEP	869,000	973,900	642,300
Repayments under credit agreement – HEP	(1,028,000)	(832,900)	(434,300)
Proceeds from issuance of senior notes - HFC	394,000	0	0
Redemption of senior notes - HEP	0	0	$ (156,188)
Repayment of financing obligation	(39,500)
Net proceeds from common unit offerings - HEP	125,870
Cash and cash equivalents:
Beginning of period	15,013
End of period	$ 3,657	$ 15,013